Immune pathogenesis of COVID-19 intoxication: storm or silence?

M Kiselevskiy, I Shubina, I Chikileva, S Sitdikova… - Pharmaceuticals, 2020 - mdpi.com
Dysregulation of the immune system undoubtedly plays an important and, perhaps,
determining role in the COVID-19 pathogenesis. While the main treatment of the COVID-19 …

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …

Host immune response and immunobiology of human SARS-CoV-2 infection

S Kumar, R Nyodu, VK Maurya, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
One of the most serious viral outbreaks of the decade, infecting humans, originated from the
city of Wuhan, China, by the end of December 2019, has left the world shaken up. It is the …

[PDF][PDF] Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019

A Kosmaczewska, I Frydecka - Pol Arch Intern Med, 2020 - scholar.archive.org
AbsTRACT Novel coronavirus disease 2019 (COVID‑19) is a highly contagious, respiratory
disease caused by the newly emerged severe acute respiratory syndrome coronavirus 2 …

Immunomodulation: a broad perspective for patients' survival of COVID-19 infection

CF Adeboboye, BO Oladejo… - European Journal of …, 2020 - journals.tmkarpinski.com
The pathogenesis of the SARS-CoV-2 virus is yet to be well understood. However, patients
with the virus show clinical manifestations which are very similar to those of SARS-CoV and …

The role of dysregulated immune responses in COVID-19 pathogenesis

S Tahaghoghi-Hajghorbani, P Zafari, E Masoumi… - Virus research, 2020 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19) which caused by severe acute
respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global …

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2

M Catanzaro, F Fagiani, M Racchi, E Corsini… - Signal transduction and …, 2020 - nature.com
To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19
and the current standard care relies on supportive treatments. Therefore, based on the fast …

Immune signature of covid-19: In-depth reasons and consequences of the cytokine storm

P Niedźwiedzka-Rystwej, A Majchrzak… - International Journal of …, 2022 - mdpi.com
In the beginning of the third year of the fight against COVID-19, the virus remains at least still
one step ahead in the pandemic “war”. The key reasons are evolving lineages and …

The immune paradox of SARS‐CoV‐2: Lymphocytopenia and autoimmunity evoking features in COVID‐19 and possible treatment modalities

J Gerlach, AM Baig, M Fabrowski… - Reviews in Medical …, 2023 - Wiley Online Library
SARS‐CoV‐2 causes multiorgan damage to vital organs and tissue that are known to be
due to a combination of tissue tropisms and cytokine‐mediated damage that it can incite in …

A “window of therapeutic opportunity” for anti-cytokine therapy in patients with coronavirus disease 2019

L De Stefano, F Bobbio-Pallavicini, A Manzo… - Frontiers in …, 2020 - frontiersin.org
The effects of cytokine inhibition in the different phases of the severe coronavirus disease
2019 (COVID-19) are currently at the center of intense debate, and preliminary results from …